NK Cell Activation in the Antitumor Response Induced by IFN-α Dendritic Cells Loaded with Apoptotic Cells from Follicular Lymphoma Patients
/in Dendritic Cells, International Publications, Malignant LymphomaHSP70L1-mediated intracellular priming of dendritic cell vaccination induces more potent CTL response against cancer
/in Dendritic Cells, International PublicationsDendritic cell vaccination in melanoma patients: From promising results to future perspectives
/in Dendritic Cells, International Publications, Malignant MelanomaAnti-tumor efficacy of the Runx2-dendritic cell vaccine in triple-negative breast cancer in vitro.
/in Breast Cancer, Dendritic Cells, International PublicationsIpilimumab administered to metastatic melanoma patients who progressed after dendritic cell vaccination
/in Dendritic Cells, International Publications, Malignant MelanomaProgress of dendritic cell-based cancer vaccines for patients with hematological malignancies
/in Acute Leukemia, Chronic Leukemia, Dendritic Cells, International PublicationsDendritic cells-based vaccine to inhibit triple-negative breast cancer cells proliferation.
/in Breast Cancer, Dendritic Cells, International PublicationsSafety and initial clinical efficacy of a dendritic cell (DC) vaccine in locally advanced, triple-negative breast cancer (TNBC) patients (pts).
/in Breast Cancer, Dendritic Cells, International PublicationsImpact of CD8 stromal lymphocytes in BC patients with the addition of autologous dendritic CELL vaccination to neoadjuvant chemotherapy.
/in Breast Cancer, Dendritic Cells, International Publications
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer